Inhaled corticosteroid withdrawal in T2-low asthma ? A randomized study of symptom and biomarker stability - Amsterdam 2025

Asthma treatments revisited: fresh data on trusted therapies

Chair(s): Reshed Abohalaka, Lies Lahousse

Session type: Poster session

Inhaled corticosteroid withdrawal in T2-low asthma ? A randomized study of symptom and biomarker stability

Christiane Hammershaimb E. Mosbech

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Effectiveness of tiotropium bromide on lung function and asthma control in real life: data from 1-year clinical follow-up

Kurtulus Aksu

Poster

Abstract

Speed of change in feeling of health: a new ePRO for asthmatic patients

Fulvio Braido

Poster

Abstract

Poor adherence to inhaled corticosteroids associated with asthma-related intensive care admissions

Ngu Wah Khine

Poster

Abstract

Asthma healthcare burden with ICS/LABA or LAMA-containing therapies: Chinese retrospective cohort study

Zhiliu Tang

Poster

Abstract

Uncontrolled asthmatics with small airways dysfunction (SAD) and response to extra-fine ICS/LABA formulation: A real-world, observational, effectiveness, multi-centre study from India

Ruby Swami

Poster

Abstract

Inhaled corticosteroid withdrawal in T2-low asthma A randomized study of symptom and biomarker stability

Christiane Hammershaimb E. Mosbech

Poster

Abstract

Long-term exacerbation trends before/after initiating triple therapy for uncontrolled asthma

Nicolas Roche

Poster

Abstract

Asthma exacerbations during pregnancy

Bohee Lee

Poster

Abstract

Long-acting muscarinic antagonists for severe asthma: the perspective of SHARP clinicians

Marco Caminati

Poster

Abstract

Bronchial hyper-reactivity impacts symptoms in severe eosinophilic asthmatic patients

Mario Di Stasio

Poster

Abstract

Persistent airway hyperresponsiveness to mannitol after high-dose ICS is linked to combined T2 inflammation and mast cell infiltration

Emilie Johanning Bari

Poster

Abstract

Understanding Perceptions and Place of Triple Therapy for Asthma Management: The ESCALATE Survey

Deepak Muthreja

Poster

Abstract

Salmeterol Induces Transcription of Genes with cAMP Response Elements

Eva Fiorenzo

Poster

Abstract

Should we be cautious of systemic side effects from nebulised ?? agonists?

Craig Mortimer

Poster

Abstract

30-35 Year Review of Spinal Skeletal Effects of Long-Term Inhaled Corticosteroids(LICS) after Asthma Admission

Martin Balzan

Poster

Abstract

Single-inhaler triple therapy (FF/UMEC/VI) vs FF/VI in Chinese uncontrolled asthma adults

Alison C Moore

Poster

Abstract

Improvement in Quality of Life in Asthma Patients switched to fixed triple combination with Beclometasone/Formoterol/Glycopyrronium: 12-Month Results of TriMaximize Study

Frederik Trinkmann

Poster

Abstract

Long-Term Asthma Control with Beclometasone/Formoterol/Glycopyrronium: 12-Month Results of TriMaximize Study

Christian Gessner

Poster

Abstract

Role of Intranasal Corticosteroid in Asthma Management: A Focus on nNO Biomarker

Jian Sun

Poster

Abstract

Reduction of asthma exacerbations after escalation from BUD/FORM or FP/SAL to FF/UMEC/VI

Stephen G Noorduyn

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}